"We all want a quick and easy fix, but remember that food, movement, community and sleep are all forms of medicine," she says
Seek urgent medical attention if you experience severe, persistent abdominal pain radiating to the back, particularly if accompanied by vomiting Hypoglycaemia : Whilst GLP-1 agonists alone rarely cause low blood glucose, the risk increases when used alongside insulin or sulfonylureas
You will also need to meet specific criteria before a doctor will approve it for you
Understanding what happens when you stop taking semaglutide helps explain why discontinuation rates concerned insurers so deeply, as weight regain after stopping was nearly universal
H.KimS.ShaiaJ.KaelberD
There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved
